• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌患者循环 CD4+CD25+Foxp3+调节性 T 细胞升高。

Elevated Circulating CD4CD25Foxp3 Regulatory T Cells in Patients with Nonsmall Cell Lung Cancer.

机构信息

1 Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, China.

2 Department of Pneumology, The First Hospital of Jilin University, Changchun, China.

出版信息

Cancer Biother Radiopharm. 2019 Jun;34(5):325-333. doi: 10.1089/cbr.2018.2672. Epub 2019 Mar 29.

DOI:10.1089/cbr.2018.2672
PMID:30925076
Abstract

CD4CD25Foxp3 regulatory T (Treg) cell-mediated immunosuppression has been implicated as a crucial mechanism of tumor immune cell escape in nonsmall cell lung cancer (NSCLC). However, little is known concerning the specific role of CD4CD25Foxp3 Treg cells in NSCLC. The aim of this study was to investigate the frequency of circulating CD4CD25Foxp3 Treg cells and their role in NSCLC. The frequencies of Treg, T helper (Th)1, Th2, and Th17 cells in peripheral blood were separately measured in 36 NSCLC patients and 20 healthy controls (HCs) using flow cytometry. Serum cytokine concentrations were determined using cytometric bead arrays. The frequencies of circulating CD4CD25 T cells and CD4CD25Foxp3 and CD4CD25Foxp3 Treg cells were significantly higher in advanced-stage NSCLC patients compared with patients with limited-stage NSCLC. The frequencies of circulating CD4CD25Foxp3 and CD4CD25Foxp3 Treg cells were negatively correlated with interleukin (IL)-17, but positively correlated with serum IL-10 levels. In addition, the Th17/CD4CD25Foxp3 Treg cell ratios were negatively correlated with serum cytokeratin 19 fragment (CYFRA 21-1) concentrations in patients with NSCLC. Moreover, coculturing CD4CD25Foxp3 Treg cells and CD14 monocytes resulted in a higher frequency of CD206CD14 M2-like monocytes compared with CD14 monocytes. Elevated circulating CD4CD25Foxp3 Treg cells may be involved in the pathogenesis of NSCLC.

摘要

CD4CD25Foxp3 调节性 T(Treg)细胞介导的免疫抑制作用被认为是非小细胞肺癌(NSCLC)中肿瘤免疫细胞逃逸的关键机制。然而,关于 CD4CD25Foxp3 Treg 细胞在 NSCLC 中的具体作用知之甚少。本研究旨在探讨循环 CD4CD25Foxp3 Treg 细胞的频率及其在 NSCLC 中的作用。采用流式细胞术分别检测 36 例 NSCLC 患者和 20 例健康对照者(HCs)外周血中 Treg、辅助性 T 细胞(Th)1、Th2 和 Th17 细胞的频率。采用细胞因子微珠阵列法测定血清细胞因子浓度。晚期 NSCLC 患者外周血中循环 CD4CD25T 细胞及 CD4CD25Foxp3 和 CD4CD25Foxp3 Treg 细胞的频率明显高于局限期 NSCLC 患者。循环 CD4CD25Foxp3 和 CD4CD25Foxp3 Treg 细胞的频率与白细胞介素(IL)-17 呈负相关,与血清 IL-10 水平呈正相关。此外,NSCLC 患者 Th17/CD4CD25Foxp3 Treg 细胞比值与血清细胞角蛋白 19 片段(CYFRA 21-1)浓度呈负相关。此外,与 CD14 单核细胞共培养 CD4CD25Foxp3 Treg 细胞可导致 CD206CD14 M2 样单核细胞的频率高于 CD14 单核细胞。循环 CD4CD25Foxp3 Treg 细胞的升高可能与 NSCLC 的发病机制有关。

相似文献

1
Elevated Circulating CD4CD25Foxp3 Regulatory T Cells in Patients with Nonsmall Cell Lung Cancer.非小细胞肺癌患者循环 CD4+CD25+Foxp3+调节性 T 细胞升高。
Cancer Biother Radiopharm. 2019 Jun;34(5):325-333. doi: 10.1089/cbr.2018.2672. Epub 2019 Mar 29.
2
Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer.非小细胞肺癌患者Th17/Treg平衡紊乱
Inflammation. 2015 Dec;38(6):2156-65. doi: 10.1007/s10753-015-0198-x.
3
Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.接受手术的非小细胞肺癌患者中CD4+CD25+FOXP3+和CD8+CD28-调节性T细胞的变化。
Int Immunopharmacol. 2014 Feb;18(2):255-61. doi: 10.1016/j.intimp.2013.12.004. Epub 2013 Dec 15.
4
Imbalance in the Th17/Treg and cytokine environment in peripheral blood of patients with adenocarcinoma and squamous cell carcinoma.腺癌和鳞癌患者外周血中 Th17/Treg 及细胞因子环境失衡。
Med Oncol. 2013 Mar;30(1):461. doi: 10.1007/s12032-013-0461-7. Epub 2013 Jan 20.
5
Expression of Th17 and CD4 CD25 T regulatory cells in peripheral blood of acute leukemia patients and their prognostic significance.急性白血病患者外周血中Th17细胞和CD4 CD25调节性T细胞的表达及其预后意义。
Pak J Pharm Sci. 2016 Nov;29(6 Suppl):2405-2410.
6
Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines.麻风病患者血清中的Th17细胞因子:与循环CD4(+) CD25(高表达)FoxP3(+)调节性T细胞以及下调细胞因子的相关性
Arch Dermatol Res. 2014 Nov;306(9):793-801. doi: 10.1007/s00403-014-1486-2. Epub 2014 Jul 14.
7
Aberrant peripheral blood CD4 CD25 FOXP3 regulatory T cells/T helper-17 number is associated with the outcome of patients with lymphoma.异常外周血 CD4 CD25 FOXP3 调节性 T 细胞/T 辅助-17 细胞数量与淋巴瘤患者的预后相关。
Cancer Immunol Immunother. 2020 Sep;69(9):1917-1928. doi: 10.1007/s00262-020-02591-y. Epub 2020 May 8.
8
Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.麻风病患者血清中Th1/Th2及巨噬细胞系细胞因子;与循环CD4(+) CD25(高) FoxP3(+)调节性T细胞的相关性
Exp Dermatol. 2014 Oct;23(10):742-7. doi: 10.1111/exd.12529.
9
Age-related changes in CD4+CD25+FOXP3+ regulatory T cells and their relationship with lung cancer.CD4+CD25+FOXP3+调节性T细胞的年龄相关变化及其与肺癌的关系。
PLoS One. 2017 Mar 2;12(3):e0173048. doi: 10.1371/journal.pone.0173048. eCollection 2017.
10
CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.晚期肺癌患者外周血中的 CD8+CD28- 细胞和 CD4+CD25+ 调节性 T 细胞。
Med Oncol. 2010 Mar;27(1):29-33. doi: 10.1007/s12032-008-9165-9. Epub 2009 Jan 16.

引用本文的文献

1
Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.同时靶向血管内皮生长因子受体2(VEGFR2)和程序性死亡受体配体1(PD-L1)可促进胸膜间皮瘤的存活和血管正常化。
Oncoimmunology. 2025 Dec;14(1):2512104. doi: 10.1080/2162402X.2025.2512104. Epub 2025 May 29.
2
The aryl hydrocarbon receptor controls IFN-γ-induced immune checkpoints PD-L1 and IDO via the JAK/STAT pathway in lung adenocarcinoma.芳烃受体通过JAK/STAT途径调控肺腺癌中IFN-γ诱导的免疫检查点PD-L1和IDO。
J Immunol. 2025 Mar 3. doi: 10.1093/jimmun/vkae023.
3
Dynamic changes of host immune response during Helicobacter pylori-induced gastric cancer development.
幽门螺杆菌诱导胃癌发生过程中宿主免疫反应的动态变化。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae109.
4
Qingfei mixture modulates the immune responses in lung cancer through modulating mTOR signaling and gut microbiota-derived short-chain fatty acids.清肺合剂通过调节mTOR信号通路和肠道微生物群衍生的短链脂肪酸来调节肺癌中的免疫反应。
Heliyon. 2024 Apr 16;10(8):e29404. doi: 10.1016/j.heliyon.2024.e29404. eCollection 2024 Apr 30.
5
Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance.紫杉醇联合化合物K通过调节Treg/Th17平衡诱导非小细胞肺癌细胞焦亡
Chin Med. 2024 Feb 15;19(1):26. doi: 10.1186/s13020-024-00904-2.
6
Targeting T regulatory (T) cells in immunotherapy-resistant cancers.在免疫治疗耐药性癌症中靶向调节性T细胞。
Cancer Drug Resist. 2024 Jan 12;7:2. doi: 10.20517/cdr.2023.46. eCollection 2024.
7
The Effect of Lung Resection for NSCLC on Circulating Immune Cells: A Pilot Study.非小细胞肺癌肺切除术后对循环免疫细胞的影响:一项初步研究。
Curr Oncol. 2023 May 17;30(5):5116-5134. doi: 10.3390/curroncol30050387.
8
Circulating T regulatory cell subsets in patients with untreated lung cancer.未经治疗的肺癌患者体内的循环 T 调节细胞亚群。
Clin Transl Oncol. 2022 Sep;24(9):1755-1763. doi: 10.1007/s12094-022-02827-6. Epub 2022 Apr 20.
9
Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.人源首例癌细胞裂解物疫苗用于胸段恶性肿瘤患者的随机II期试验。
Transl Lung Cancer Res. 2021 Jul;10(7):3079-3092. doi: 10.21037/tlcr-21-1.
10
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.纳入 NADIM 临床试验的接受新辅助化疗免疫治疗的 NSCLC 患者中与完全病理缓解相关的血液生物标志物。
Clin Transl Med. 2021 Jul;11(7):e491. doi: 10.1002/ctm2.491.